Tuesday, January 20, 2015

Zosano Pharma Expected To IPO Next Week

Fremont-based Zosano Pharma, which develops a transdermal drug delivery system, is expected to price its IPO on Tuesday, January 27th, according to industry information. The company has filed for an IPO as ZSAN on the NASDAQ Capital Market. The firm is selling 3,000,000 shares of its stock, and currently estimates its IPO pricing at between $10.00 and $12.00 per share. Zosano is venture backed by BMV, New Enterprise Associates, Eli Lilly, and others.